R

R&G PharmaStudies Co Ltd
SZSE:301333

Watchlist Manager
R&G PharmaStudies Co Ltd
SZSE:301333
Watchlist
Price: 51.88 CNY 1.63% Market Closed
Market Cap: 5B CNY
Have any thoughts about
R&G PharmaStudies Co Ltd?
Write Note

Relative Value

The Relative Value of one R&G PharmaStudies Co Ltd stock under the Base Case scenario is 48.38 CNY. Compared to the current market price of 51.88 CNY, R&G PharmaStudies Co Ltd is Overvalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
48.38 CNY
Overvaluation 7%
Relative Value
Price
R
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
17
vs Industry
24
Median 3Y
6.6
Median 5Y
6.6
Industry
4.1
Forward
6.1
vs History
17
vs Industry
15
Median 3Y
35.8
Median 5Y
35.8
Industry
32.7
Forward
37.2
vs History
34
vs Industry
18
Median 3Y
24.2
Median 5Y
24.2
Industry
22.1
vs History
37
vs Industry
17
Median 3Y
27.7
Median 5Y
27.7
Industry
33.6
vs History
17
vs Industry
35
Median 3Y
2.6
Median 5Y
2.6
Industry
2.6
vs History
13
vs Industry
35
Median 3Y
4.2
Median 5Y
4.2
Industry
3.9
Forward
4
vs History
17
vs Industry
26
Median 3Y
11
Median 5Y
11
Industry
8.6
vs History
17
vs Industry
15
Median 3Y
25.2
Median 5Y
25.2
Industry
18.5
Forward
20
vs History
17
vs Industry
19
Median 3Y
25.2
Median 5Y
25.2
Industry
23.7
Forward
14.7
vs History
27
vs Industry
32
Median 3Y
15.5
Median 5Y
15.5
Industry
21.4
vs History
31
vs Industry
27
Median 3Y
18.1
Median 5Y
18.1
Industry
28.8
vs History
17
vs Industry
10
Median 3Y
7.1
Median 5Y
7.1
Industry
2.4

Multiples Across Competitors

Competitors Multiples
R&G PharmaStudies Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
R&G PharmaStudies Co Ltd
SZSE:301333
5B CNY 6.7 36.9 27.6 27.6
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 455.6 4 876 1 538.7 3 279.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
202B USD 4.8 33 21.3 30.6
US
Danaher Corp
NYSE:DHR
166.7B USD 7.8 42.8 26.9 40.4
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.7B USD 6 30.1 22.4 26.1
US
IQVIA Holdings Inc
NYSE:IQV
36.2B USD 2.4 25.8 14.2 21.6
US
Mettler-Toledo International Inc
NYSE:MTD
27B USD 7.2 34 24.3 27.1
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.4 48.1 32.3 40.6
CN
WuXi AppTec Co Ltd
SSE:603259
164.4B CNY 4.3 20.4 14.8 14.8

See Also

Discover More
Back to Top